Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000154532 | SCV000204204 | likely benign | not specified | 2018-11-26 | criteria provided, single submitter | clinical testing | proposed classification - variant undergoing re-assessment, contact laboratory |
Gene |
RCV001530401 | SCV000235984 | likely benign | not provided | 2020-04-20 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function |
Invitae | RCV001438008 | SCV001640875 | likely benign | Myofibrillar myopathy 4 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002399539 | SCV002709919 | likely benign | Cardiovascular phenotype | 2018-06-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002505169 | SCV002797363 | likely benign | Dilated cardiomyopathy 1C; Myofibrillar myopathy 4 | 2021-10-12 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003965148 | SCV004776839 | likely benign | LDB3-related disorder | 2020-07-15 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |